Vinit Makkar is an Oncology physician affiliated with Cleveland Clinic. OpenAlex indexes 6 publications with 530 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave
Cleveland, OH 441950001
Telephone
800-223-2273Registry record last updated 5 Feb 2008.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- JAZZ PHARMACEUTICALS INC.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- Becton, Dickinson and CompanyProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
48.3%Aromatase Inhibitor24.1%Anastrozole47%Letrozole45%Exemestane9%Part D<11 patientsKinase inhibitor6%Jakafi33%Brukinsa17%Ibrance17%Imbruvica17%Calquence15%Part D<11 patients+ 6 more classes in this area
Metabolism & gastrointestinal
12.7%Corticosteroid3.5%Prednisone100%Part D≥18 patientsProton pump inhibitor3.2%Pantoprazole Sodium60%Omeprazole40%Part D<11 patients+ 4 more classes in this area
Blood & clotting
11.9%Factor Xa inhibitor8.9%Eliquis78%Xarelto22%Part D<11 patientsThrombopoietin Receptor Agonist3%Promacta100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Esophageal Dose Tolerance to Hypofractionated Stereotactic Body Radiation Therapy: Risk Factors for Late Toxicity
International Journal of Radiation Oncology*Biology*Physics
2014 - Prothrombin 20209C>T: 16 new cases, association with the 19911A>G polymorphism, and literature review
Journal of Thrombosis and Haemostasis
2009 - A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer.
PubMed
2002
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Lars Svensson, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Gene Barnett, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”